Yuflyma

1 minute read

Business

Hikma and Celltrion sign exclusive licensing agreement for YuflymaTM for the Middle East and North Africa region

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces an exclusive licensing agreement with…

bySarjatha Kp

July 18, 2022

The Latest

HEI Global Health and S&P Universal Consulting Appoint Mr. Brian Raggett to Lead Middle East Expansion and Strategic Partnerships

TCL Displays the Future of Visual Technologies and Intelligent Living with Groundbreaking Products and Solutions at CES 2026

Token Economy Leader Open World and VerifyMe Announce Plans to List on Nasdaq via Proposed Strategic Merger

Hikma and Celltrion sign exclusive licensing agreement for YuflymaTM for the Middle East and North Africa region

HEI Global Health and S&P Universal Consulting Appoint Mr. Brian Raggett to Lead Middle East Expansion and Strategic Partnerships

TCL Displays the Future of Visual Technologies and Intelligent Living with Groundbreaking Products and Solutions at CES 2026

Token Economy Leader Open World and VerifyMe Announce Plans to List on Nasdaq via Proposed Strategic Merger

Paris Saint-Germain Partners With Zing Coach Until 2027 to Encourage Fans to Get Active Through Interactive Fitness Experiences

BlueFive Capital Appointed as GP for CICC–Hebei Development Fund

OSP and Gulfstream Services Announce Global Strategic Technology Alliance for Next-Generation Cementing Solutions

Abu Dhabi’s TII Launches Falcon-H1 Arabic, Establishing the World’s Leading Arabic AI Model